Yüklüyor......
SEOM Clinical Guideline for the treatment of pancreatic cancer (2016)
Pancreatic cancer remains an aggressive disease with a 5 year survival rate of 5%. Only 15% of patients with pancreatic cancer are eligible for radical surgery. Evidence suggests a benefit on survival with adjuvant chemotherapy (gemcitabine o fluourouracil) after R1/R0 resection. Adjuvant chemoradio...
Kaydedildi:
| Yayımlandı: | Clin Transl Oncol |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Springer International Publishing
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5138250/ https://ncbi.nlm.nih.gov/pubmed/27896637 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12094-016-1586-x |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|